Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SRX3177
Cat. No.:
0225LY-1276
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
SRX3177 is a powerful novel inhibitor targeting CDK, PI3K, and BRD4, possessing significant potential for anticancer therapy.
Synonym:
2241237-51-2; 7-cyclopentyl-N,N-dimethyl-2-({4-[5-(morpholin-4-yl)-7-oxo-7H-thieno[3,2-b]pyran-3-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide; 7-Cyclopentyl-N,N-dimethyl-2-[[4-(5-morpholino-7-oxo-7H-thieno[3,2-b]pyran-3-yl)phenyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide; 7-cyclopentyl-N,N-dimethyl-2-((4-(5-morpholino-7-oxo-7H-thieno[3,2-b]pyran-3-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide
CAS No.:
2241237-51-2
Compound CID:
153289441
Formula:
C31H32N6O4S
Formula Weight:
584.69
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SRX3177 can be used in molecular biology to investigate the selective degradation or inhibition of specific CDK isoforms.
Library Information
Target:
Epigenetic reader domain; PI3K; CDK
Receptor:
PI3K; CDK; BRD4
Pathways:
Chromatin/Epigenetic; Cell cycle/Checkpoint; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-17
Plate Location:
d3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
20 mg/mL; 34.21 mM
